While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

An insider's look at Florida’s war on invaders: the giant snakes, egg-eating predators and parasites spreading through the ...

Professional python hunter Amy Siewe recently posted a video on her Facebook page showing her cutting open a snake's egg to see what it looks like.

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Ian Bartoszek may know more about Burmese pythons than anyone who has ever walked Earth. Program director for the Conservancy of Southwest Florida's world-renowned Burmese python capture and removal ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

Japanese startup Sakana AI has founded the "Sakana AI RSI Lab," a research group focused on recursive self-improvement (RSI). The goal is to explore how AI can speed up and improve the development of ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Artificial intelligence (AI) may not be building better versions of itself yet, but Anthropic says the world is moving closer to that possibility than many people realize. In a new research paper ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Anthropic now reports that Claude writes more than 80% of the code it ships. The figures that read as a safety warning also describe a business whose output scales with compute rather than headcount.

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...